Referring to reports of Takeda being in talks to acquire Cipla or Lupin Pharma, Lupin Ltd has clarified that it is not in discussions with Takeda for the purpose of selling its domestic formulations business, the report is baseless and speculative in nature and does not merit any explanation from the company. Cipla Ltd has also categorically denied it.

Kiri Industries Ltd , manufacturer and exporter of dyes, has bagged a $20 million per annum (approximately Rs 100 crore) export order for supplies to South-East Asia, which is over and above the normal expected sales targeted in the current financial year. KIL also owns DyStar, the dyestuff company with operations across the world. Mr Manish Kiri, MD of KIL, was confident that the landmark order will allow KIL to penetrate into one of the largest textile producers globally with its entire product range. KIL has a product mix of specialty and commodity products together as one basket, allowing it to increase its average sales price and average margins.

L&T has said that L&T Construction secured new orders worth Rs 1,340 crore during the second quarter of FY2O11 for the construction of commercial and residential buildings, including add-on orders from ongoing projects. They included orders aggregating Rs 975 crore for the construction of a mixed use commercial development and construction of the main civil works for an IT campus from reputed customers, an order valued at Rs 203 crore for the construction of a residential tower from a leading developer and add-on orders worth Rs 162 crore from various clients for ongoing contracts. These further enhance the order book of the company, which has already secured major design & build contracts in airports, IT parks, commercial and residential space.

Related Topics
comment COMMENT NOW